The Fund supports networks of state health policy decision makers to help identify, inspire, and inform policy leaders.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
The Fund identifies and shares policy ideas and analysis to advance state health leadership, strong primary care, and sustainable health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is is a foundation that works to improve population health and health equity.
December 1991 (Volume 69)
Quarterly Article
Robert J. Levine
Nov 5, 2024
Oct 30, 2024
Oct 23, 2024
Back to The Milbank Quarterly
Any attempt at medicalization of cocaine, heroin, marijuana, and other psychoactive substances of abuse in the United States is likely to encounter strong opposition by many responsible physicians. Such opposition would be grounded in their perception that medicalization would be contrary to the purposes of medical practice. Most physicians would, however, be willing to consider prescribing such substances for pathological users if such prescribing took place within the context of a fully developed doctor-patient relationship in which the patient recognized the dependency as undesirable and wanted to cooperate with the physician in a mutual effort to end the dependency or, if this were not feasible, to mitigate its destructive effects.
Author(s): Robert J. Levine
Download the Article
Read on JSTOR
Volume 69, Issue 4 (pages 623–640) Published in 1991